MaxCyte, Inc. (MXCT)
NASDAQ·Healthcare·Biotechnology
$1.28
+1.19%
Mkt Cap $130.04M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+370.6%
Consensus $6.00 vs current $1.28
NASDAQ·Healthcare·Biotechnology
$1.28
+1.19%
Mkt Cap $130.04M
No recent rating data.
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
+370.6%
Consensus $6.00 vs current $1.28